Clinical Trials Directory

Predicting DVT Risk in GI Cancer Patients Using Plasma Biomarkers

To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.

Stanford is now accepting new patients for this trial. Please contact Fizaa Ahmed at 650-725-6409 for more information.

Investigator(s):

Intervention(s):

  • procedure : Observation

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Male or female, >= 18 years old. There are no ethnic restrictions. - Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease - Ability to understand and the willingness to sign a written informed consent document. - Existing staging CT imaging study

External Links

Stanford Medicine Resources:

Footer Links: